Results 76 - 100 from 148 for "antibiotice"
-
Antibiotice Iasi Sales Revenue Up 3%, Net Profit Up 14% In First 9 Months Of 2017
11.15.2017
-
Antibiotice Iasi GM: Romania Has Europe's Lowest Drug Prices And World's Highest Clawback Tax
09.13.2017
-
Antibiotice Iasi Posts Higher Profit, Of RON19.19M, In 1H/2017
08.17.2017
-
Antibiotice Iasi 1Q Profit Down 26% To RON5.3M, Turnover Up 1% To RON55.4M
05.15.2017
-
Antibiotice Iasi To Pay Dividends At A 4% Yield From 2016 Profit
03.06.2017
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) will pay dividends of RON0.023/share from 2016 profit, at a 4.1% yield, the company said in a statement to Bucharest Stock Exchange Monday. more
-
Antibiotice Iasi To Boost Production Of Creams, Ointments And Gels
01.20.2017
A number of 60 million drug packs leave the plant of pharmaceutical producer Antibiotice Iasi annually, 35% to 40% of which topical products (creams, ointments, gels), says chief executive Ioan Nani, more
-
SIF Oltenia Buys 780,000 Shares In Antibiotice Iasi For RON395,000
12.15.2016
-
Antibiotice Iasi Ceases Payment Of 2012 Dividends As Of November
10.17.2016
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) will cease the payment of dividends from 2012 profit as of November 1, 2016, the company said in a statement Monday. more
-
Ioan Nani, Antibiotice Iasi: Clawback Tax Became A Drawback For Drugmakers
10.02.2016
The medicine industry is more and more affected by the clawback tax, as the tax currently accounts for approximately 30% of the value added of a drugmaker, which will soon lead to the collapse of drug more
-
Antibiotice Iasi Sales Up 9% In January-June
08.01.2016
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported sales of RON143.8 million in January-June 2016, up 9% from the year-earlier period. more
-
Antibiotice Iasi Seeks RON30M Loan From UniCredit Bank
07.11.2016
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) has called a shareholders' meeting for August 11 to approve the contracting of a RON30 million (EUR6.7 million) loan from a UniCredit Bank. more
-
Antibiotice Iasi Exported $3.4M Worth Of Injectable Drugs To U.S. This Year
07.07.2016
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) in June finished the delivery of a $3.4 million order for injectable medicines to the United States. more
-
Antibiotice Iasi 1Q Profit Up 18% To RON7.1M
05.17.2016
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported a profit of RON7.1 million in January-March 2016, up 18% from the year-earlier period. more
-
Antibiotice Iasi 1Q Turnover Up 5% To RON55.1M
05.13.2016
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported a turnover of RON55.1 million in the first quarter of 2016, up 5% from RON52.6 million in the year-earlier period and 1% higher than the more
-
Antibiotice Iasi Eyes 6% Higher Revenue, Profit In 2016
04.20.2016
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) targets revenues of RON350 million and a gross profit of RON34.2 million in 2016, both 6% higher on the year, given negative factors such as the more
-
Antibiotice Profit Down To RON27.1M In 2015
02.15.2016
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported a net profit of RON27.1 million in 2015, down from RON31.1 million a year before, but higher than forecasted, the company said in a more
-
Antibiotice Iasi Suspends Pay Of Remaining Dividends For 2011's Profit
09.16.2015
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Tuesday said on the Bucharest Stock Exchange it will suspend the payment of the dividends due for 2011 and not cashed by the stockholders, on more
-
Antibiotice Iasi 1H Sales Revenue Down 11.6% To EUR30M
08.10.2015
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported 11.6% lower sales revenue in the first half of 2015, to RON132.39 million (EUR30 million), in the context in which the local market was more
-
Antibiotice Iasi Seeks Investors To Boost Production Capacity
05.28.2015
State-run pharmaceutical producer Antibiotice Iasi (ATB.RO) intends to build two more manufacturing lines in a total investment of EUR40 million and secure the necessary funding by attracting a more
-
Antibiotice 1Q Net Profit Up 15% To RON6M
05.15.2015
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported a net profit of 6 million lei (EUR1.4 million) for the first quarter, up 15% on the year, the company said in a statement Friday. more
-
Antibiotice To Pay Dividends of RON15.7M
04.30.2015
Shareholders of Romanian pharmaceutical producer Antibiotice Iasi (ATB.RO) Thursday approved the payment of dividends worth 15.74 million lei (EUR3.5 million), or half of last year’s profit, the more
-
Antibiotice To Pay Half Of 2014 Profit As Dividends
03.27.2015
Romanian pharmaceutical producer Antibiotice Iasi (ATB.RO) plans to pay dividends of 15.74 million lei (EUR3.5 million), about half of last year’s net profit, according to documents prepared for the more
-
Antibiotice Iasi 2015 Net Profit Seen Down 32% To RON21.2M
03.12.2015
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) estimates its net profit will fall by 32% to RON21.26 million (nearly EUR4.8 million) in 2015, from RON31.29 million a year before. more
-
Antibiotice Iasi Posts 0.5% Higher Sales Revenue And Flat Profit In 2014
02.13.2015
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) on Friday said its sales revenue inched up 0.5% on the year in 2014, to 318.9 million lei (EUR71.8 million), while its profit stagnated at nearly more
-
Antibiotice Iasi To Develop New Drugs With Indian Pharma Companies - The Economic Times
01.09.2015
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) will collaborate with three Indian pharmaceutical companies to research and develop new drugs, according to Indian publication The Economic more